“The defining challenge of the AI era is no longer invention alone. It is execution,” writes Nigel Vaz.

In June 2026, Integra LifeSciences Holdings announced a reshaped commercial leadership team, including new executives to oversee Tissue Reconstruction and Specialty Surgery, following the earlier ...